Bispecific antibody-based salvage therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bispecific antibody-based salvage therapy, covering 2025-06-17 to 2025-06-17. Get the full timeline:
Most recent: Clinical Trial Update: Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma [Phase 2]